The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Regulatory T-cell inhibition plus antitumor immunotherapy targeted against cytomegalovirus (CMV) in patients with newly diagnosed glioblastoma multiforme (GBM).
Gordana Vlahovic
No relevant relationships to disclose
Gerald E. Archer
No relevant relationships to disclose
Denise Lally-Goss
No relevant relationships to disclose
Sharon Norman
No relevant relationships to disclose
Annick Desjardins
No relevant relationships to disclose
Katherine B. Peters
No relevant relationships to disclose
Tulika Ranjan
No relevant relationships to disclose
Jason Watts
No relevant relationships to disclose
Patrick Healy
No relevant relationships to disclose
James Emmett Herndon
No relevant relationships to disclose
Henry S. Friedman
No relevant relationships to disclose
Allan H. Friedman
No relevant relationships to disclose
Darell D. Bigner
No relevant relationships to disclose
John Howard Sampson
No relevant relationships to disclose